Biodesix, Inc. (BDSX)
Nasdaq: BDSX · Services-Medical Laboratories · Louisville, CO · filing with the SEC since 2008
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Feb 26, 2026 | Mar 3, 2025 | Mar 1, 2024 | Mar 6, 2023 | Mar 14, 2022 | Mar 16, 2021 | · |
| Revenue | 88,499 | 71,323 | 49,087 | 38,212 | 54,506 | 45,557 | 24,552 |
| For lenders | |||||||
| Provision for credit losses | 180 | 887 | 497 | · | · | · | · |
| Research and development | 12,001 | 9,559 | 9,988 | 13,102 | 12,789 | 10,818 | 10,468 |
| Selling, general and administrative | 87,545 | 80,451 | 67,387 | 61,462 | 50,517 | 34,857 | 30,637 |
| Sales and marketing | 7,562 | 7,574 | 7,195 | · | · | · | · |
| Total operating expenses | 116,372 | 105,821 | 90,429 | 88,799 | 95,446 | 68,491 | 51,293 |
| Operating income | -27,873 | -34,498 | -41,342 | -50,587 | -40,940 | -22,934 | -26,741 |
| Interest expense | 7,716 | 8,258 | 9,536 | 8,072 | 4,508 | 7,604 | 3,008 |
| Interest and investment income | · | · | · | · | · | 18 | 55 |
| Other income (expense), net | · | · | -10,804 | -14,860 | -2,219 | -8,416 | -3,985 |
| Total non-operating income (expense) | -7,392 | -8,433 | -10,804 | · | · | · | · |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | · |
| Net income including non-controlling interests | -35,265 | -42,931 | -52,146 | -65,447 | -43,159 | -31,350 | -30,726 |
| Net income | -35,265 | -42,931 | -52,146 | -65,447 | -43,159 | -65,447r | -30,726 |
| Earnings per share, basic | -4.67 | -6.64r | -12.80b | -31.00b | -31.60b | · | · |
| Earnings per share, diluted | -4.67 | -6.64r | -12.80b | -31.00b | -31.60b | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -31.60b | -129.60b | -2,539.40b |
| Weighted average shares, basic | 7,551,000 | 6,470,000r | 4,105,650b | 2,105,150b | 1,368,250b | · | · |
| Weighted average shares, diluted | 7,551,000 | 6,470,000r | 4,105,650b | 2,105,150b | 1,368,250b | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 1,368,250b | 241,900b | 12,100b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split of Sep 2025.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesProvision for credit losses set aside for loans that may not be repaid
us-gaap:ProvisionForLoanLeaseAndOtherLossesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpense
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted